TY - JOUR
T1 - Further evidence needed to change policy for the safe and effective radical cure of vivax malaria
T2 - Insights from the 2019 annual APMEN Vivax Working Group meeting
AU - Ruwanpura, Varunika Sonani Hapuwatte
AU - Nowak, Spike
AU - Gerth-Guyette, Emily
AU - Theodora, Minerva
AU - Dysoley, Lek
AU - Haile, Mebratom
AU - Peeters Grietens, Koen
AU - Price, Ric Norman
AU - Lynch, Caroline Anita
AU - Thriemer, Kamala
PY - 2021/5
Y1 - 2021/5
N2 - New diagnostics and treatment options for the radical cure of Plasmodium vivax malaria are now available. At the 2019 annual meeting of the Vivax Working Group of the Asia Pacific Malaria Elimination Network, participants took part in a roundtable discussion to identify further evidence required to introduce these new tools into policy and practice. Key gaps identified were accuracy and reliability of glucose-6-phosphate-dehydrogenase deficiency tests, health system capacity, and feasibility and cost effectiveness of novel treatment strategies in routine clinical practice. As expected, there were differences in the priorities between country partners and researcher partners. To achieve the 2030 target for the regional elimination of malaria, evidence to address these issues should be generated as a matter of priority. Review of global guidelines alongside locally generated data will help to ensure the timely revision and optimisation of national treatment guidelines that will be vital to meet regional elimination goals.
AB - New diagnostics and treatment options for the radical cure of Plasmodium vivax malaria are now available. At the 2019 annual meeting of the Vivax Working Group of the Asia Pacific Malaria Elimination Network, participants took part in a roundtable discussion to identify further evidence required to introduce these new tools into policy and practice. Key gaps identified were accuracy and reliability of glucose-6-phosphate-dehydrogenase deficiency tests, health system capacity, and feasibility and cost effectiveness of novel treatment strategies in routine clinical practice. As expected, there were differences in the priorities between country partners and researcher partners. To achieve the 2030 target for the regional elimination of malaria, evidence to address these issues should be generated as a matter of priority. Review of global guidelines alongside locally generated data will help to ensure the timely revision and optimisation of national treatment guidelines that will be vital to meet regional elimination goals.
KW - Asia Pacific
KW - evidence gaps
KW - malaria elimination
KW - malaria health policy
KW - Plasmodium vivax malaria
KW - policy implementation
KW - radical cure
UR - http://www.scopus.com/inward/record.url?scp=85099228780&partnerID=8YFLogxK
U2 - 10.1002/app5.314
DO - 10.1002/app5.314
M3 - Article
C2 - 34820128
AN - SCOPUS:85099228780
SN - 2050-2680
VL - 8
SP - 208
EP - 242
JO - Asia and the Pacific Policy Studies
JF - Asia and the Pacific Policy Studies
IS - 2
ER -
